Table 3.
Estimated slopes (change) from Pre to Post treatment (S1) and post to 12MFU (S2), and effect sizes (Cohen’s d) for pair-wise group slope comparisons for CBT vs. ACT, ACT vs. WL and CBT vs. WL
| CBT | ACT | WL | CBT vs. |
ACT vs. |
CBT vs. |
|
|---|---|---|---|---|---|---|
| beta (95% CI) | beta (95% CI) | beta (95% CI) | ACT d12 |
WL d |
WL d |
|
| SYMPTOMS | ||||||
| Composite Symptom Scale | ||||||
| S1 | −1.0 (−1.3 to −.7)*** | −1.1 (−1.4 to −0.8)*** | −0.2 (−0.5 to 0.1) | 0.11 | .97 | 1.02 |
| S2 | −0.1 (−0.3 to 0.0) | 0.0 (−0.2 to 0.1) | -- | 0.23 | -- | -- |
| Clinical Severity Rating | ||||||
| S1 | −2.4 (−3.0 to −1.9)*** | −1.8 (−2.4 to −1.2)*** | −0.3 (−0.9 to 0.3) | 0.62 | 1.51 | 2.19 |
| S2 | 0.0 (−0.3 to 0.4) | −0.1 (−0.4 to 0.2) | -- | 0.16 | -- | -- |
| Fear & Avoidance Ratings | ||||||
| S1 | −32.6 (−44.1 to −21.2)*** | −21.8 (−33.2 to −10.3)*** | −3.8 (−15.8 to 8.2) | .43 | .60 | 1.04 |
| S2 | −1.5 (−7.1 to 4.1) | −5.0 (−10.2 to 0.2) | -- | .31 | -- | -- |
| QUALITY OF LIFE | ||||||
| QOLI (higher numbers indicate improvement) | ||||||
| S1 | 0.4 (−0.1 to 0.9) | 0.1 (−0.4 to 0.5) | 0.1 (−0.4 to 0.6) | 0.23 | 0.00 | 0.26 |
| S2 | 0.0 (−0.2 to 0.3) | 0.2 (−0.1 to 0.5) | -- | 0.17 | -- | -- |
| PUBLIC SPEAKING | ||||||
| SUDS during speech | ||||||
| S1 | −26.6 (−38.3 to −14.8)*** | −22.7 (−33.9 to −11.6)*** | −16.3 (−27.9 to −4.8)** | 0.15 | 0.26 | 0.44 |
| S2 | 3.9 (−3.0 to 10.9) | −5.4 (−11.8 to 1.0) | -- | 0.80 | -- | -- |